EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Total neoadjuvant therapy for locally advanced rectal cancer: a narrative review

Elías Gomis Sellés iD, Daniela Gonsalves Pieretti, Paula Peleteiro Higuero, Elisabet González Del Portillo, Virginia Morillo Macías, María Mateos Domínguez, Raquel Fuentes Mateos, Fernando López-Campos, Ana Aurora Díaz-Gavela, Gustavo Ferraris, Felipe Couñago

Future Oncology · 2023-08 · 19 (25) · 1753-1768

DOI: 10.2217/fon-2023-0481 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Future Oncology, online erschienen am 31.08.2023. Verfasst von Elías Gomis Sellés und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University Hospital Virgen del Rocío, Biomedical Institute of Seville (IBIS)/CSIC/University of Seville, Seville, 4…. Hauptthemen laut MEDLINE: Neoplasms, Second Primary, Rectal Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: Janssen; consulting.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Locally advanced rectal cancer has traditionally been treated with chemoradiotherapy (CRT) followed by surgery and adjuvant chemotherapy. However, a new strategy, total neoadjuvant therapy, involves the administration of CRT and neoadjuvant chemotherapy with the aim of eradicating micrometastases earlier and achieving greater control of the disease. The use of total neoadjuvant therapy has shown higher rates of pathological complete response and resectability compared with CRT, including improved survival. Nevertheless, distant relapse is the main cause of morbidity and mortality in locally advanced rectal cancer. To address this, new biomarkers are being developed to predict disease response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasms, Second PrimaryRectal NeoplasmsHumansNeoadjuvant TherapyChemoradiotherapyChemotherapy, Adjuvant

Stichwörter der Autor:innen

LARCbiomarkerschemotherapypathological complete responseradiotherapyrectal cancertotal neoadjuvant therapy

Autor:innen und Institutionen

  • Department of Radiation Oncology, University Hospital Virgen del Rocío, Biomedical Institute of Seville (IBIS)/CSIC/University of Seville, Seville, 41013, Spain.
  • Department of Radiation Oncology, Genesiscare, Madrid, 28002, Spain.
  • Department of Radiation Oncology, University Hospital Santiago de Compostela, 15706, Santiago de Compostela, Spain.
  • Department of Radiation Oncology, University Hospital La Paz, Madrid, 28046, Spain.
  • Department of Radiation Oncology, Castellón Provincial Hospital, Castellón, 12002, Spain.
  • Department of Medical Oncology, University Hospital Ramón y Cajal, Madrid, 28034, Spain.

ORCID-Profile: Elías Gomis Sellés

Förderung

  • Janssen; consulting

Zitieren

APA

Sellés, E. G., Pieretti, D. G., Higuero, P. P., Del Portillo, E. G., Macías, V. M., Domínguez, M. M., Mateos, R. F., López-Campos, F., Díaz-Gavela, A. A., Ferraris, G., & Couñago, F. (2023). Total neoadjuvant therapy for locally advanced rectal cancer: a narrative review. Future Oncology, 19(25), 1753-1768. https://doi.org/10.2217/fon-2023-0481

Vancouver

Sellés EG, Pieretti DG, Higuero PP, Del Portillo EG, Macías VM, Domínguez MM, et al. Total neoadjuvant therapy for locally advanced rectal cancer: a narrative review. Future Oncology. 2023;19(25):1753-1768. doi:10.2217/fon-2023-0481

BibTeX
@article{Sells2023,
  author = {Sellés, Elías Gomis and Pieretti, Daniela Gonsalves and Higuero, Paula Peleteiro and Del Portillo, Elisabet González and Macías, Virginia Morillo and Domínguez, María Mateos and Mateos, Raquel Fuentes and López-Campos, Fernando and Díaz-Gavela, Ana Aurora and Ferraris, Gustavo and Couñago, Felipe},
  title = {Total neoadjuvant therapy for locally advanced rectal cancer: a narrative review},
  journal = {Future Oncology},
  year = {2023},
  volume = {19},
  number = {25},
  pages = {1753--1768},
  doi = {10.2217/fon-2023-0481}
}
Kostenlos starten →